Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments - Additional Information (Details)

v3.21.2
Financial Instruments - Additional Information (Details)
$ in Thousands
Sep. 30, 2021
USD ($)
Pandologic Ltd [Member]  
Contingent Consideration Liabilities [Line Items]  
Contingent Consideration $ 1,261